University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Amber Vitamins A and D capsules

Specialist recommendation.

Status: Amber Vortioxetine (Brintellix)

Specialist initiation only and RICaD

Status: Amber Warfarin tablets

First choice. BSSE APC preferred agent. This recommendation must only be taken into account after a patient and prescriber have discussed all treatment options (including warfarin) and only if they have no preference about which medicine they want to use. To be initiated by those who have the appropriate skills and experience.

Use should be in line with local commissioning arrangements - for BCC CCG - Anticoagulation AQP. Ensure that patients prescribed anticoagulants receive appropriate verbal and written information at the start of therapy, at hospital discharge, on the first anticoagulant clinic appointment, and when necessary throughout the course of their treatment (NPSA Alert 18)

Status: Amber Xalacom eye drops

Specialist ophthalmologist recommendation

Status: Green Xylometazoline 0.1% nasal spray/drops

Short term use only

Status: Red Zinc and salicylic acid paste (Lassar’s paste) half-strength

Unlicensed special

Status: Green Zolmitriptan

Tablets, orodispersible tablets and nasal spray

Status: Red Zuclopenthixol decanoate injection

APC verdict - present status = RED (Future status = AMBER with a framework in primary care before transfer - commissioning discussion)  

Status: Amber Zuclopenthixol tablets

Specialist initiation only, ESCA

Building healthier lives
Back to top